Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Complement component c1q and anti-c1q antibodies in theory and in clinical practice

E Potlukova, P Kralikova

. 2008 ; 67 (5) : 423-430.

Language English Country Great Britain

Grant support
NR8352 MZ0 CEP Register

Digital library NLK
Full text - Article
Source

E-resources

NLK Free Medical Journals from 1997 to 1 year ago
Medline Complete (EBSCOhost) from 1972-01-01 to 1 year ago
Wiley Online Library (archiv) from 1997-01-01 to 2012-12-31
Wiley Free Content from 1997 to 1 year ago

The complement system is a major part of the innate immunity. The first component of the classical pathway of complement activation, C1q, plays a crucial role in the clearance of immune complexes and apoptotic bodies from the organism. Autoantibodies against C1q (anti-C1q) have been found in a number of autoimmune and infectious diseases. They have been best described in patients with systemic lupus erythematosus, where they are thought to play a pathogenic role in lupus nephritis (LN). Their high negative predictive value for the occurrence of active proliferative LN, as well as their possible ability to indicate a renal flare as soon as 6 months in advance, have rendered anti-C1q antibodies a novel non-invasive tool in the detection of active LN.

000      
02316naa 2200385 a 4500
001      
bmc11003236
003      
CZ-PrNML
005      
20131011093936.0
008      
110225s2008 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Potluková, Eliška $7 jx20070605017
245    10
$a Complement component c1q and anti-c1q antibodies in theory and in clinical practice / $c E Potlukova, P Kralikova
314    __
$a Third Clinic of Medicine, General Teaching Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic. eliska.potlukova@seznam.cz
520    9_
$a The complement system is a major part of the innate immunity. The first component of the classical pathway of complement activation, C1q, plays a crucial role in the clearance of immune complexes and apoptotic bodies from the organism. Autoantibodies against C1q (anti-C1q) have been found in a number of autoimmune and infectious diseases. They have been best described in patients with systemic lupus erythematosus, where they are thought to play a pathogenic role in lupus nephritis (LN). Their high negative predictive value for the occurrence of active proliferative LN, as well as their possible ability to indicate a renal flare as soon as 6 months in advance, have rendered anti-C1q antibodies a novel non-invasive tool in the detection of active LN.
650    _2
$a zvířata $7 D000818
650    _2
$a imunokomplex $x imunologie $7 D000936
650    _2
$a apoptóza $x imunologie $7 D017209
650    _2
$a autoprotilátky $x krev $7 D001323
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a komplement C1q $x imunologie $7 D015922
650    _2
$a klasická dráha komplementu $7 D003171
650    _2
$a progrese nemoci $7 D018450
650    _2
$a lidé $7 D006801
650    _2
$a přirozená imunita $7 D007113
650    _2
$a systémový lupus erythematodes $x imunologie $x krev $7 D008180
650    _2
$a nefritida při lupus erythematodes $x diagnóza $x imunologie $7 D008181
650    _2
$a financování organizované $7 D005381
700    1_
$a Králíková, Petra, $d 1979- $7 xx0110555
773    0_
$t Scandinavian Journal of Immunology $w MED00010600 $g Roč. 67, č. 5 (2008), s. 423-430
910    __
$a ABA008 $b x $y 7 $z 0
990    __
$a 20110413120053 $b ABA008
991    __
$a 20131011094500 $b ABA008
999    __
$a ok $b bmc $g 830589 $s 695229
BAS    __
$a 3
BMC    __
$a 2008 $b 67 $c 5 $d 423-430 $m Scandinavian journal of immunology $n Scand J Immunol $x MED00010600
GRA    __
$a NR8352 $p MZ0
LZP    __
$a 2011-2B/ipme

Find record